Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Worldwide Clinical Trials
CRO
Fortrea boosts early-phase platform with $45M acquisition
Fortrea has agreed to acquire the early-phase services division of fellow CRO Worldwide Clinical Trials for $45 million.
Will Maddox
Sep 2, 2026 3:06pm
Worldwide Clinical Trials adds Catalyst to global CRO mixture
Jan 20, 2026 2:54pm
Worldwide Clinical Trials taps former Syneos leader as CEO
Sep 16, 2025 6:55am
Worldwide turns to AI to dig patient subpopulations out of data
Apr 8, 2025 3:20pm
Acadia brings BMS vet on board as CEO—Chutes & Ladders
Sep 27, 2024 8:30am
Worldwide completes pharmacy expansion at Texas site
Feb 21, 2024 3:20pm
